Bayesian inference on protective antibody levels using case-control data

Biometrics

Volumn 57, Issue 1, 2001, Pages 135-142

  Carey, Vincent J ^a   Baker, Carol J ^b   Platt, Richard ^a  

^a CHANNING LABORATORY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bayesian estimation and inference; Immunoepidemiology; Sensitivity analysis; Vaccine design

Indexed keywords

BAYESIAN NETWORKS; DISEASE CONTROL; INFERENCE ENGINES; RISK PERCEPTION; SENSITIVITY ANALYSIS;

ANTIBODY CONCENTRATION; BAYESIAN ESTIMATIONS; BAYESIAN INFERENCE; CASE-CONTROL; CONTROL DATA; IMMUNE RESPONSE; IMMUNOEPIDEMIOLOGY; INFECTIOUS PATHOGENS; POSTERIOR DISTRIBUTIONS; VACCINE DESIGN;

ANTIBODIES;

ANTIBODY BLOOD LEVEL; ARTICLE; BAYES THEOREM; CASE CONTROL STUDY; DATA ANALYSIS; IMMUNE RESPONSE; INFECTION RISK; STATISTICAL ANALYSIS;

EID: 0035105349     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2001.00135.x     Document Type: Article

References (15)

1. A hierarchical Bayesian model to predict the duration of immunity to H. influenzae type b
2. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcus infection
3. Methods of inference for estimates of absolute risk derived from population-based case-control studies
4. Quantal response curves for experimentally uncontrolled variables
5. The protective level of serum antibodies in the capsular polysaccharide of Haemophilus influenzae type b
6. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi vi capsular polysaccharide vaccine three years after immunization
7. A study of logspline density estimation
8. Estimation of absolute risk front nested case-control data
9. Surface structures of group B streptococcus important in human immunity
10. Implementing MCMC
11. Quantitative measurement of "natural" and immunization induced Haemophilus influenzae type b capsular polysaccharide antibodies
12. Hepatitis B: A case study in MCMC methods
13. Bayesian design for dose-response curves with penalized risk
14. Case-control studies and Bayesian inference